Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 27.60%-1.67M | 59.26%-369.65K | -5.95%-304.32K | 42.74%-404.98K | -47.18%-586.51K | -87.52%-2.3M | -113.43%-907.24K | -287.23K | -345.49%-707.27K | 38.01%-398.49K |
| Net income from continuing operations | 27.83%-1.79M | 21.29%-525.9K | 27.43%-273.93K | 28.95%-514.35K | 33.05%-475.42K | -151.76%-2.48M | -76.29%-668.18K | ---377.48K | -212.22%-723.96K | -89.84%-710.06K |
| Operating gains losses | --32.19K | --115.53K | 3,752.22%32.17K | 411.58%9.5K | -357,242.86%-125K | ---- | ---- | --835 | 111.00%1.86K | -84.85%35 |
| Depreciation and amortization | 340.31%5.61K | 4,957.66%5.61K | --0 | --0 | --0 | -50.00%1.28K | -90.51%111 | --0 | 28.57%540 | -35.00%624 |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Remuneration paid in stock | 43.53%174.99K | 3,529.43%47.77K | -99.24%942 | --2.27K | --124.01K | 17.05%121.92K | -834.90%-1.39K | --123.31K | --0 | --0 |
| Other non cashItems | ---155.63K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 19.04%66.97K | 160.82%142.97K | -87.32%-63.5K | 582.69%97.6K | -135.41%-110.1K | 120.48%56.26K | -5,499.09%-235.05K | ---33.9K | -77.96%14.3K | 192.71%310.91K |
| -Change in receivables | -183.52%-3.59K | 36.11%-2.82K | -171.34%-2.55K | -41.63%4.44K | -7.70%-2.66K | -94.75%4.3K | 80.35%-4.41K | --3.57K | -92.84%7.61K | -22.97%-2.47K |
| -Change in prepaid assets | -108.15%-252 | -52.71%4.76K | -82.80%1.22K | 580.44%6.19K | 17.11%-12.43K | 90.22%3.09K | -44.50%10.07K | --7.1K | -87.98%910 | 37.75%-14.99K |
| -Change in payables and accrued expense | 44.89%70.81K | 158.59%141.03K | -39.48%-62.18K | 1,404.34%86.97K | -128.93%-95.01K | 113.65%48.87K | -197,400.00%-240.71K | ---44.58K | 111.81%5.78K | 206.18%328.37K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 27.60%-1.67M | 59.26%-369.65K | -5.95%-304.32K | 42.74%-404.98K | -47.18%-586.51K | -87.52%-2.3M | -113.43%-907.24K | ---287.23K | -345.49%-707.27K | 38.01%-398.49K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 95.39K | -20.11K | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net PPE purchase and sale | ---15.29K | ---130.79K | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | ---2.16K | ---- | ---- | ---- | ---- | --0 | ---- | --0 | --0 | --0 |
| Net other investing changes | --112.84K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --95.39K | ---20.11K | --0 | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -29.95%1.68M | -92.56%55.1K | 349.73%661.37K | -46.73%365.68K | -27.50%597.55K | 1,025.94%2.4M | 740.25K | 147.06K | 686.49K | 286.99%824.19K |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --1.48M | ---31.29K | --0 | 422.33%686.49K | 286.99%824.19K |
| Proceeds from stock option exercised by employees | 82.85%1.68M | -94.00%55.1K | --661.37K | --365.68K | --597.55K | --918.59K | --918.59K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -29.95%1.68M | -92.56%55.1K | 349.73%661.37K | -46.73%365.68K | -27.50%597.55K | 1,025.94%2.4M | --740.25K | --147.06K | --686.49K | 286.99%824.19K |
| Net cash flow | ||||||||||
| Beginning cash position | 24.69%348.6K | 46.87%792.03K | -37.48%422.66K | -48.68%357.88K | 24.69%348.6K | -77.09%279.58K | -23.22%539.27K | -3.74%676.08K | -18.26%697.36K | -77.09%279.58K |
| Current changes in cash | 12.12%109.61K | -100.86%-335.4K | 355.25%357.79K | 466.66%76.19K | -97.41%11.04K | 110.35%97.76K | 60.72%-166.99K | ---140.17K | 86.91%-20.78K | 218.01%425.7K |
| Effect of exchange rate changes | 54.28%-13.14K | 51.22%-11.55K | 244.31%11.58K | -2,162.50%-11.4K | 77.72%-1.76K | -865.65%-28.74K | -1,139.96%-23.68K | --3.36K | -106.32%-504 | -21.72%-7.91K |
| End cash Position | 27.68%445.08K | 27.68%445.08K | 46.87%792.03K | -37.48%422.66K | -48.68%357.88K | 24.69%348.6K | 24.69%348.6K | -23.22%539.27K | -3.74%676.08K | -18.26%697.36K |
| Free cash from | 26.93%-1.68M | 57.57%-384.94K | -5.95%-304.32K | 42.74%-404.98K | -47.18%-586.51K | -87.52%-2.3M | -113.43%-907.24K | ---287.23K | -345.49%-707.27K | 38.01%-398.49K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.